Article Listing - J&J unit Janssen-Cilag withdraws MAA for Comfyde based on negative CHMP feedback

PHARMA ECONOMICS 1942/1992 PERSPECTIVE

23 March 1992

Enoch Powell, who was Minister of Health in the UK back in the 60s, and responsible for what would now...

FROM A RESEARCH-LED TO A MARKET-DRIVEN FIRM

23 March 1992

The task ofpharmaceutical industry management is to achieve the best possible balance between the constant pull of the market...

ESTRAPAK FOR OSTEOPOROSIS IN UK

23 March 1992

Ciba-Geigy's transdermal hormone replacement therapy Estrapak 50, which combines an estrogen patch and progestogen tablets for endometrial protection, is now...

FORTHCOMING MEETINGS

23 March 1992

The following Rostrum-organized meetings of potential interest to pharmaceutical industry personnel will be held at The Royal Society of Medicine,...

UK REGULATIONS ON HIV TESTING

23 March 1992

New regulations by the UK government aimed at controlling the sale and use of HIV testing kits will come into...

USER FEES URGED IN ONTARIO

23 March 1992

In Canada, the drug benefit program operated by the province of Ontario should introduce "modest" user fees to encourage patients,...

STRONGER WARNINGS ON ACE INHIBITORS

23 March 1992

At the request of the US Food and Drug Administration, six manufacturers of ACE inhibitors are putting stronger warning labels...

SOMATOGEN'S rhB1.1 BLOOD SUBSTITUTE

23 March 1992

A collaborative research project between Somatogen and the UK Medical Research Council's Laboratory of Molecular Biology, Cambridge, has published a...

STOCK MARKET COMMENTARY: TOKYO

23 March 1992

TOKYO: stocks fell below the psychologically important 20,000 yen level last week to a five-year low. The decline was a...

STOCK MARKET COMMENTARY: EUROPE

23 March 1992

EUROPE: stock markets were nearly all down, with the lead coming from New York and Tokyo. On the FRANKFURT exchange,...

Showing 94561-94570 of 95329 articles